Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, Gwénaël Ferron et al.|The Lancet Oncology|2024Cited by 70
Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysisF. Gouin, Eberhard Stoeckle, Charles Honoré et al.|BMC Cancer|2022Cited by 14
Improved Metastatic-Free Survival after Systematic Re-Excision Following Complete Macroscopic Unplanned Excision of Limb or Trunk Soft Tissue SarcomaF. Gouin, Jean‐Yves Blay, Audrey Michot et al.|Cancers|2024Cited by 7
Neoadjuvant chemotherapy associated with enhanced local control in radiation-induced angiosarcoma of breast and chestAudrey Michot, Eberhard Stoeckle, Marie Karanian et al.|European Journal of Surgical Oncology|2023Cited by 1
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (CHIPOR): A Randomized, Open-Label, Phase 3 TrialJean-Marc Classe, Olivier Gléhen, Pierre Méeus et al.|Obstetrical & Gynecological Survey|2025Cited by 0